Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3685results about How to "Effective isolation" patented technology

Nuclear reprogramming factor and induced pluripotent stem cells

The present invention relates to a nuclear reprogramming factor having an action of reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell. The present invention also relates to the aforementioned iPS cells, methods of generating and maintaining iPS cells, and methods of using iPS cells, including screening and testing methods as well as methods of stem cell therapy. The present invention also relates to somatic cells derived by inducing differentiation of the aforementioned iPS cells.
Owner:KYOTO UNIV

Methods and compositions for isolating small RNA molecules

InactiveUS20050059024A1Efficiently isolateEffective isolationSugar derivativesMicrobiological testing/measurementMolecular biologyIsolation procedures
The present invention concerns the use of methods and compositions for the isolation of small RNA molecules (100 nucleotides or fewer), such as microRNA and siRNA molecules. Such molecules are routinely lost in commonly used isolation procedures and therefore the present invention allows for a much higher level of enrichment or isolation of these small RNA molecules.
Owner:APPL BIOSYSTEMS INC

Nuclear reprogramming factor and induced pluripotent stem cells

The present invention relates to a nuclear reprogramming factor having an action of reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell. The present invention also relates to the aforementioned iPS cells, methods of generating and maintaining iPS cells, and methods of using iPS cells, including screening and testing methods as well as methods of stem cell therapy. The present invention also relates to somatic cells derived by inducing differentiation of the aforementioned iPS cells.
Owner:KYOTO UNIV

Barrier device for ostium of left atrial appendage

A membrane applied to the ostium of an atrial appendage for blocking blood from entering the atrial appendage which can form blood clots therein is disclosed. The membrane also prevents blood clots in the atrial appendage from escaping therefrom and entering the blood stream which can result in a blocked blood vessel, leading to strokes and heart attacks. The membranes are percutaneously installed in patients experiencing atrial fibrillations and other heart conditions where thrombosis may form in the atrial appendages. A variety of means for securing the membranes in place are disclosed. The membranes may be held in place over the ostium of the atrial appendage or fill the inside of the atrial appendage. The means for holding the membranes in place over the ostium of the atrial appendages include prongs, stents, anchors with tethers or springs, disks with tethers or springs, umbrellas, spiral springs filling the atrial appendages, and adhesives. After the membrane is in place a filler substance may be added inside the atrial appendage to reduce the volume, help seal the membrane against the ostium or clot the blood in the atrial appendage. The membranes may have anticoagulants to help prevent thrombosis. The membranes be porous such that endothelial cells cover the membrane presenting a living membrane wall to prevent thrombosis. The membranes may have means to center the membranes over the ostium. Sensors may be attached to the membrane to provide information about the patient.
Owner:BOSTON SCI SCIMED INC

Securing stored content for trusted hosts and safe computing environments

Techniques for protecting content to ensure its use in a trusted environment are disclosed. The stored content is protected against harmful and/or defective host (or hosted) environments. A trusted security component provided for a device can verify the internal integrity of the stored content and the host before it allows the content to come in contact with the host. As a counter part, a trusted security component provided for the host can verify and attest to the integrity of the host and/or specific host computing environment that can be provided for the content stored in the device. The trusted security component provided for a device effectively verify the host integrity based on the information attested to by the trusted security component provided for the host. If the trusted security component trusts the host, it allows the trusted host to provide a trusted host computing environment trusted to be safe for the content stored in the device. A trusted host can effectively provide a safe virtual environment that allows a content representing a copy (or image) of an original computing environment to operate on the host computing system to give a similar appearance as the original computing environment.
Owner:SAMSUNG ELECTRONICS CO LTD

Systems and methods for expedited data transfer in a communication system using hash segmentation

The present invention provides for an improved method and system for determining differences in data sets or data files, expedited data transfer and data reconciliation in a communication network using hash segmentation processing. The system and method provides for an efficient means of communicating updated files, new revisions or verifying files between a source host and a target host. By implementing hash segmentation processing, and in many embodiments iterative hash segmentation processing, the updates within the files can be isolated for the purpose of minimizing the amount of data communicated from the source host to the target host. The system and methods provide for the transfer of data between two hosts in instances in which neither host is aware of the revision that exists on the other host. The hash segmentation process may implement a logarithmic hash approach or a sliding linear hash approach.
Owner:HAND HELD PRODS

Multiple degree of freedom substrate manipulator

A system for manipulating a planar substrate such as a semiconductor wafer is provided. The manipulator is typically used in conjunction with an XY stage to focus and planarize a wafer with respect to a tool. The manipulator employs redundant actuators of different types and a control system that uses low-bandwidth, high efficiency actuators to provide low frequency forces and high-bandwidth, but less efficient, actuators to provide all other forces. The manipulator provides support and manipulation of a substrate while minimizing errors due to thermal distortion.
Owner:ACTIVE PRECISION

Seedling planting method in alkaline land

The invention discloses a seedling planting method in an alkaline land. The method comprises the steps of: digging planting pits, laying a salt and alkali isolating layer, laying a water storage layer, laying a percolation layer, backfilling planting soil and cultivating seedlings. By adopting the seedling planting method in the alkaline land disclosed by the invention, the salt and alkali are effectively isolated, drought defying and waterlogging control are realized, the survival rate of the seedling is improved, and the normal growth of the seedlings is ensured; large-area consolidation of the alkaline land is not needed, and only the local plot, in which the seedlings are planted, is needed to be consolidated, so that the seedlings can be planted; and the method is simple, feasible and worthy of popularizing.
Owner:SHANDONG SUNWAY LANDSCAPE TECH

Compositions for Encapsulation and Controlled Release

InactiveUS20080063714A1Effective isolationUnfavorable interactionPowder deliveryBiocideDrugChemistry
The invention comprises compositions and methods useful for encapsulation and controlled release of guest molecules, such as drugs. Compositions of the present invention comprise a matrix comprising molecules that are non-covalently crosslinked by multi-valent cations, wherein the molecules that are non-covalently crosslinked are non-polymeric, have more than one carboxy functional group, and have at least partial aromatic or heteroaromatic character The compositions are characterized in that a guest molecule may be encapsulated within the matrix and subsequently released.
Owner:3M INNOVATIVE PROPERTIES CO

Barrier device for ostium of left atrial appendage

A membrane applied to the ostium of an atrial appendage for blocking blood from entering the atrial appendage which can form blood clots therein is disclosed. The membrane also prevents blood clots in the atrial appendage from escaping therefrom and entering the blood stream which can result in a blocked blood vessel, leading to strokes and heart attacks. The membranes are percutaneously installed in patients experiencing atrial fibrillations and other heart conditions where thrombosis may form in the atrial appendages. A variety of means for securing the membranes in place are disclosed. The membranes may be held in place over the ostium of the atrial appendage or fill the inside of the atrial appendage. The means for holding the membranes in place over the ostium of the atrial appendages include prongs, stents, anchors with tethers or springs, disks with tethers or springs, umbrellas, spiral springs filling the atrial appendages, and adhesives. After the membrane is in place a filler substance may be added inside the atrial appendage to reduce the volume, help seal the membrane against the ostium or clot the blood in the atrial appendage. The membranes may have anticoagulants to help prevent thrombosis. The membranes be porous such that endothelial cells cover the membrane presenting a living membrane wall to prevent thrombosis. The membranes may have means to center the membranes over the ostium. Sensors may be attached to the membrane to provide information about the patient.
Owner:BOSTON SCI SCIMED INC

Olefin two-phase hydroformylation method

The invention relates to an olefin two-phase hydroformylation method, which consists of three parts: polyether guanidine mesylate ionic liquid (PGMILs) with room temperature solidifiable characteristics, complex catalysts (Rh-TPPTS) formed by RhCl3.3H2O or dicarbonylacetylacetonato rhodium and triphenylphosphine sodium trithionate (TPPTS), and reactants of C6-C14 straight chain 1-olefin, wherein the Rh-TPPTS is dissolved in the PGMILs to form a lower layer catalyst phase, the C6-C14 straight chain 1-olefin or product aldehyde forms an upper layer organic phase, the selectivity of high-carbon aldehyde is 85 to 99 percent, the mol ratio of normal aldehyde to isomerism aldehyde is 2.0 to 2.4, the PGMILs phase containing Rh-TPPTS can be cyclically used for 35 times, the activity and the selectivity are unchanged, the accumulated conversion number (TON) reaches higher than 30000, rhodium flowing to the product phase is 0.04 percent to 0.07 percent, and ultra-long-period catalysis activity and selectivity can be realized.
Owner:山东聚强绿洲生物科技有限公司

Vibration reducing blower assembly mounting

A medical device, such as a respiratory treatment device, includes a passive acoustic noise reduction system in the form of a vibration reducing blower assembly isolation mount. The device includes a housing, a blower assembly mounted therein, a patient circuit coupled to the blower assembly, and a noise reducing blower assembly isolation mount. The mount includes a first vibration damping member adjacent one side of the blower assembly spacing the blower assembly from a mounting surface upon which the blower assembly is supported. A securing member positions and holds the blower assembly onto the mounting surface, and a second vibration damping member adjacent an opposite side of the blower assembly spaces the blower assembly from the securing member. The vibration damping members are injection molded thermoplastic elastomeric members.
Owner:RIC INVESTMENTS LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products